# Association of chemotherapy-induced nausea and vomiting or anorexia with plasma levels of five gastrointestinal peptides in patients receiving chemotherapy

**Authors:** Ryosuke Tatsuta, Ryota Tanaka, Asami Tashibu, Yosuke Suzuki, Kosuke Suzuki, Tomotaka Shibata, Tadasuke Ando, Toshitaka Shin, Yuhki Sato, Hiroki Itoh

PMC · DOI: 10.1186/s40780-025-00424-7 · Journal of Pharmaceutical Health Care and Sciences · 2025-03-05

## TL;DR

This study explores how changes in five gastrointestinal peptides relate to chemotherapy-induced nausea, vomiting, and anorexia in cancer patients.

## Contribution

The study identifies motilin and leptin as potential quantitative indicators for CINV and anorexia, respectively.

## Key findings

- Plasma motilin levels were significantly higher in patients with CINV compared to those without.
- Leptin levels remained elevated longer in patients with anorexia than in those without.
- NPY and leptin increased early, while motilin and substance P increased later during chemotherapy.

## Abstract

Imbalance between gastrointestinal peptides has been implicated as a cause of chemotherapy-induced nausea and vomiting (CINV) and anorexia in cancer patients. This study comprehensively evaluated the changes in blood levels of five gastrointestinal peptide: substance P, neuropeptide (NPY), motilin, ghrelin and leptin, following chemotherapy, and the relationship between these peptides and CINV or anorexia.

This single-center, prospective, observational study recruited 20 patients with esophageal cancer, urothelial cancer, or testiculoma undergoing cisplatin-based chemotherapy. Plasma levels of five gastrointestinal peptides were measured on days 1 (baseline; before administering chemotherapy), 3, 5 and 8 of the chemotherapy session. Anorexia and CINV were defined as visual analog scale scores 25 mm or higher at least once during the observation period.

Plasma NPY and leptin were significantly elevated in the early phase (day 3) of the chemotherapy session, while plasma motilin and substance P were significantly elevated in the late phase (days 5 and 8). Plasma motilin showed significant elevation on days 5 and 8 compared to baseline in CINV group but no significant increase in non-CINV group, and the levels were significantly higher in CINV than in non-CINV group. Plasma leptin peaked significantly on day 3 in both anorexia and non-anorexia groups, and remained significantly higher on day 5 compared to baseline in anorexia group but not in non-anorexia group.

CINV is associated with excessive secretion of motilin and anorexia is related to sustained elevation of leptin, suggesting the potential of these peptides as quantitative indicators of CINV and anorexia.

The online version contains supplementary material available at 10.1186/s40780-025-00424-7.

## Linked entities

- **Proteins:** mlnl (motilin-like), GHRL (ghrelin and obestatin prepropeptide), lepa (leptin a)
- **Chemicals:** cisplatin (PubChem CID 5460033)
- **Diseases:** esophageal cancer (MONDO:0007576)

## Full-text entities

- **Genes:** LEP (leptin) [NCBI Gene 3952] {aka LEPD, OB, OBS}, MLN (motilin) [NCBI Gene 4295], NPY (neuropeptide Y) [NCBI Gene 4852] {aka PYY4}, TAC1 (tachykinin precursor 1) [NCBI Gene 6863] {aka Hs.2563, NK2, NKNA, NPK, TAC2}
- **Diseases:** CINV (MESH:D020250), cancer (MESH:D009369), esophageal cancer (MESH:D004938), urothelial cancer (MESH:D014523), Anorexia (MESH:D000855)
- **Chemicals:** cisplatin (MESH:D002945)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11881272/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11881272/full.md

---
Source: https://tomesphere.com/paper/PMC11881272